CD BioSciences, a US-based biotechnology company focusing on the development of imaging technologies, is proud to introduce its new Multiple Organ System Tissue Microarrays for histology researchers to study a wide range of biological processes and diseases across multiple organ systems. These microarrays provide a powerful tool for comprehensive and efficient high-throughput analysis of...
CD BioSciences, a US-based biotechnology company focusing on the development of imaging technologies, is glad to announce the expansion of its product portfolio with comprehensive Endocrine System Tissue Microarrays to accelerate the study and understanding of the complex endocrine system. These microarrays will enable scientists to investigate the intricacies of the endocrine system and its...
CD BioSciences, a US-based biotechnology company focusing on the development of imaging technologies, is pleased to announce the launch of its new line of Circulatory System Tissue Microarrays to the scientific community. This new product line offers researchers a powerful tool to study a wide range of diseases affecting the heart, blood vessels, and spleen.
CD BioSciences is committed to...
CD BioSciences, a US-based biotechnology company focusing on the development of imaging technologies, is proud to announce the launch of its new line of user-friendly Tissue Clearing Kits and Reagents. These innovative products are designed to help researchers achieve more detailed imaging of tissue samples, thereby advancing the field of biomedical research.
Tissue clearance techniques allow...
CD BioSciences, a US-based biotechnology company focusing on the development of imaging technologies, is proud to announce the launch of its new Multicolor Immunofluorescence Staining Kits. These kits empower researchers to achieve high-quality staining of tissues and cells utilizing 2-7 different colors, enabling more detailed and comprehensive analysis.
By providing researchers with the tools...
CD BioSciences, a US-based biotechnology company focusing on the development of imaging technologies, proudly announces an extensive portfolio of Nervous System Tissue Microarrays designed to support neuroscience research. This comprehensive collection provides researchers with a unique resource to study various neurological conditions and accelerate their investigations into neurological...
CD BioSciences, a US-based biotechnology company focusing on the development of imaging technologies, is delighted to announce the addition of a new line of IHC Ancillaries to its product portfolio, including deparaffinators, retrievers and enzymes, washers and detergents, diluents and blockers, and mounting media. These ancillaries are developed to facilitate IHC research and diagnostics,...
CD BioSciences, a US-based biotechnology company focusing on the development of imaging technology, has announced the launch of its new range of In Vivo Imaging Reagents, including fluorescent imaging probes, fluorescent labeling dyes, fluorescent imaging panels, and fluorescent nanoparticles, designed to provide researchers with a non-invasive approach to visualize and quantify cellular and...
CD BioSciences, a US-based CRO serving the global life science research community, has announced the launch of its new services to study the Mechanistic Target of Rapamycin (mTOR) in diabetes and metabolism research.
The mechanistic Target of Rapamycin is a serine/threonine protein kinase that is inhibited by rapamycin, a bacterial compound originally isolated from Easter Island soil that...
CD BioSciences, a US-based biotechnology company focusing on the development of imaging technology, has announced the launch of its innovative line of Chromogenic Substrates for immunohistochemistry (IHC). These cutting-edge substrates offer superior signal sensitivity, long-term storage stability, enhanced safety, and user-friendliness, empowering researchers to unlock deeper insights into...
Arabic
Français
Español
Português
Deutsch
Türkçe
Dutch
Italiano
Russian
Romaian